Critical Comparison: Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) & Intelligent Bio Solutions (NASDAQ:INBS)

Intelligent Bio Solutions (NASDAQ:INBS) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Earnings & Valuation

This table compares Intelligent Bio Solutions and Fresenius SE & Co. KGaA”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$2.94 million	4.49	-$10.16 million	N/A	N/A
Fresenius SE & Co. KGaA	$24.01 billion	1.18	$382.05 million	$0.19	66.74

Fresenius SE & Co. KGaA has higher revenue and earnings than Intelligent Bio Solutions.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Intelligent Bio Solutions and Fresenius SE & Co. KGaA, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	0	0	0	0	0.00
Fresenius SE & Co. KGaA	0	0	2	1	3.33

Institutional & Insider Ownership

33.0% of Intelligent Bio Solutions shares are held by institutional investors. 1.5% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Intelligent Bio Solutions and Fresenius SE & Co. KGaA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-323.79%	-146.03%	-83.62%
Fresenius SE & Co. KGaA	N/A	3.72%	1.67%

Volatility & Risk

Intelligent Bio Solutions has a beta of 4.58, indicating that its stock price is 358% more volatile than the S&P 500. Comparatively, Fresenius SE & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Summary

Fresenius SE & Co. KGaA beats Intelligent Bio Solutions on 8 of the 12 factors compared between the two stocks.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.